Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Total Voting Rights

30 Dec 2014 07:00

RNS Number : 8604A
Fitbug Holdings PLC
30 December 2014
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

30 December 2014

Fitbug Holdings plc ('Fitbug' or 'the Company')

Total Voting Rights

 

Further to the announcement of 9 December 2014, Fitbug Holdings Plc, the AIM quoted provider of online personal health and wellbeing services, is pleased to confirm that the 39,002,224 Placing Shares and 33,333,333 Loan Conversion Shares have now been admitted to trading on AIM, effective 30 December 2014.

 

Fergus Kee, Executive Chairman, said, "I would like to take this opportunity to welcome new shareholders to the Company and thank existing investors for their continued support. With the help of these funds and strong prospects, I believe that Fitbug is now entering a very exciting period as we start the new year."

 

Following Admission of the Placing Shares and Loan Conversion Shares, for the purposes of the FCA's Disclosure and Transparency Rules, the Company advises that the total number of shares in issue and total voting rights will be 240,850,530 Ordinary Shares of 1 pence each.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.

 

Upon Admission, the Placing Shares will represent 16.19 per cent. and the Loan Conversion Shares 13.84 per cent. of the enlarged share capital. The Placing Shares and Loan Conversion Shares will rank pari passu with the existing Ordinary Shares, including the right to all dividends and other distributions, paid or made after the date of issue.

 

Following the Admission of these shares to AIM, the directors below now hold the following shares in the Company:

 

Shareholder No. of Shares % of issued share capital

 

Fergus Kee 22,916,667 9.51%

David Turner* 12,515,000 5.20%

Allan Fisher** 10,890,000 4.52%

Paul Landau 8,788,894 3.65%

 

* Persons connected with David Turner have an interest in 6,280,000 ordinary shares representing 2.61 per cent. of the issued share capital of the Company

** Persons connected with Allan Fisher have an interest in 6,280,000 ordinary shares representing 2.61 per cent. of the issued share capital of the Company

 

**ENDS**

 

For further information visit www.kiqplan.com or www.fitbugholdings.com contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce / William Lynne / Niall Pearson

Hybridan LLP, Broker and advisor to the placing

0203 713 4580/4582/4583

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

 

 

 

Notes

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement. Its "Kiqplan"TM digital health coaching platform is designed to make wearable technology relevant to new audiences and take the "so what?" out of activity tracking by providing structured action plans to help people get fitter, lighter and lead happier, healthier lives.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. Increasingly, Fitbug's platforms act as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com and wwwkiqplan.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRPGGAWPUPCGAB
Date   Source Headline
17th Dec 20219:06 amRNSSecond Price Monitoring Extn
17th Dec 20219:00 amRNSPrice Monitoring Extension
17th Dec 20217:01 amRNSTrading Update
17th Dec 20217:00 amRNSTwo-year commercial deal with Azerion
14th Dec 202111:06 amRNSSecond Price Monitoring Extn
14th Dec 202111:00 amRNSPrice Monitoring Extension
13th Dec 202112:05 pmRNSBidstack adds three new titles to its portfolio
13th Dec 202111:06 amRNSSecond Price Monitoring Extn
13th Dec 202111:00 amRNSPrice Monitoring Extension
10th Dec 20212:00 pmRNSBidstack Secures Deal with AAA Game Publisher
9th Dec 20213:22 pmRNSChange of Company Secretary
17th Nov 20217:00 amRNSBidstack expands its portfolio with Dovetail Games
11th Nov 20217:00 amRNSBidstack Serves an Ace with Tennis Clash
8th Nov 20214:35 pmRNSPrice Monitoring Extension
1st Nov 202111:05 amRNSSecond Price Monitoring Extn
1st Nov 202111:00 amRNSPrice Monitoring Extension
25th Oct 20217:00 amRNSBidstack Launches New In-Menu Ad Format
11th Oct 20217:00 amRNSBidstack lands two new titles with Illusion Labs
7th Oct 20212:00 pmRNSBidstack Adds First Interactive Story Game
30th Sep 20217:00 amRNSDirectorate Change
14th Sep 20217:00 amRNSBidstack Scores Third Title From Inlogic
2nd Sep 20217:00 amRNSInterim Results - six months ended 30 June 2021
27th Aug 20218:37 amRNSBidstack land new partnership with Suji Games
26th Aug 20217:00 amRNSMotionlab Interactive partnership
28th Jul 20217:00 amRNSBidstack races ahead with new T-Bull partnership
27th Jul 20214:40 pmRNSSecond Price Monitoring Extn
27th Jul 20214:35 pmRNSPrice Monitoring Extension
27th Jul 20212:27 pmRNSGrant of Share Options, PDMR Dealing
27th Jul 20212:09 pmRNSTR-1: Notification of major holdings
27th Jul 20217:00 amRNSTR-1: Notification of major holdings
23rd Jul 20211:10 pmRNSReplacement: Admission of Ordinary Shares & TVR
23rd Jul 20218:23 amRNSDirector/PDMR Shareholdings
23rd Jul 20218:13 amRNSNew Director
23rd Jul 20218:05 amRNSAdmission of New Ordinary Shares and TVR
19th Jul 202112:07 pmRNSResults of General Meeting
14th Jul 20217:00 amRNSUpdate on General Meeting and Admission Date
9th Jul 202110:00 amRNSExclusive Partnership with Rebound Capital Games
9th Jul 20217:00 amRNSExclusive Partnership with Nordeus
2nd Jul 20215:54 pmRNSPosting of Circular and Notice of General Meeting
2nd Jul 20211:57 pmRNSInitiation of research coverage
2nd Jul 20219:38 amRNSResults of Fundraise
1st Jul 20215:30 pmRNSProposed New Director
1st Jul 20215:15 pmRNS£10m Fundraise by way of an Accelerated Bookbuild
23rd Jun 20217:00 amRNSExpiry of Block Listing and Total Voting Rights
17th May 20214:41 pmRNSSecond Price Monitoring Extn
17th May 20214:36 pmRNSPrice Monitoring Extension
29th Apr 20216:12 pmRNSReplacement: Board Changes
29th Apr 20217:00 amRNSKatherine Hays joins as Strategic Adviser
22nd Apr 202112:50 pmRNS2021 AGM Results
22nd Apr 20217:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.